Universal Historical Cash Flow

UHS Stock

USD 205.00 1.50 0.74%

Analysis of Universal Health cash flow over time is an excellent tool to project Universal Health Services future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 14.3 M or Free Cash Flow of 551 M as it is a great indicator of Universal Health ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Universal Health Services latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Universal Health Services is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universal Health Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Universal Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Universal balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Universal's non-liquid assets can be easily converted into cash.

Universal Health Cash Flow Chart

At this time, Universal Health's Change To Netincome is comparatively stable compared to the past year. Net Borrowings is likely to gain to about 743.8 M in 2024, despite the fact that Other Cashflows From Financing Activities is likely to grow to (4.2 M).

Begin Period Cash Flow Dividends Paid Capital Expenditures Net Income End Period Cash Flow Total Cashflows From Investing Activities

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Universal Health Services to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Universal Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Universal Health Services financial statement analysis. It represents the amount of money remaining after all of Universal Health Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.

Most accounts from Universal Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Universal Health Services current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universal Health Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2021	2022	2023	2024 (projected)
Capital Expenditures	855.7M	734.0M	743.1M	434.0M
Dividends Paid	65.9M	58.4M	55.5M	34.3M

Capital Expenditures Dividends Paid

Universal Health cash flow statement Correlations

	Sale Purchase Of Stock	Change In Cash	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Dividends Paid	Capital Expenditures	Net Income	End Period Cash Flow	Stock Based Compensation	Change To Account Receivables	Change To Netincome	Change Receivables	Net Borrowings	Cash And Cash Equivalents Changes	Cash Flows Other Operating	Change To Liabilities	Investments	Exchange Rate Changes	Change To Operating Activities	Issuance Of Capital Stock
Sale Purchase Of Stock		0.54	0.01	0.18	-0.8	-0.7	0.71	-0.72	-0.31	-0.54	-0.06	-0.78	0.14	-0.77	-0.44	-0.53	0.67	0.26	-0.05	0.26	-0.61	0.58	-0.69
Change In Cash	0.54		0.72	0.66	-0.69	-0.02	0.67	-0.52	-0.08	-0.02	0.68	-0.05	-0.36	-0.14	-0.54	-0.13	0.71	0.71	0.39	0.0	0.02	0.95	-0.11
Free Cash Flow	0.01	0.72		0.75	-0.16	0.39	0.19	-0.27	-0.09	0.4	0.83	0.38	-0.26	0.3	-0.44	0.02	0.49	0.79	0.5	0.09	0.51	0.69	0.2
Change In Working Capital	0.18	0.66	0.75		-0.02	0.1	-0.03	-0.32	0.14	0.35	0.88	0.06	-0.02	-0.08	-0.6	-0.1	0.68	0.82	0.76	0.12	0.12	0.77	0.03
Begin Period Cash Flow	-0.8	-0.69	-0.16	-0.02		0.39	-0.97	0.53	0.21	0.44	0.06	0.42	0.18	0.36	0.31	0.23	-0.52	-0.25	0.1	0.05	0.4	-0.63	0.52
Depreciation	-0.7	-0.02	0.39	0.1	0.39		-0.36	0.63	0.5	0.69	0.36	0.92	-0.53	0.8	0.04	0.85	-0.42	-0.03	0.2	-0.42	0.64	-0.15	0.72
Other Non Cash Items	0.71	0.67	0.19	-0.03	-0.97	-0.36		-0.52	-0.33	-0.51	-0.06	-0.33	-0.25	-0.25	-0.22	-0.25	0.43	0.24	-0.19	-0.06	-0.24	0.58	-0.42
Dividends Paid	-0.72	-0.52	-0.27	-0.32	0.53	0.63	-0.52		0.64	0.53	-0.18	0.56	-0.17	0.58	0.3	0.7	-0.62	-0.39	0.0	-0.25	0.34	-0.57	0.45
Capital Expenditures	-0.31	-0.08	-0.09	0.14	0.21	0.5	-0.33	0.64		0.72	0.09	0.31	-0.09	0.17	-0.24	0.68	-0.03	0.02	0.57	-0.32	-0.12	-0.04	0.06
Net Income	-0.54	-0.02	0.4	0.35	0.44	0.69	-0.51	0.53	0.72		0.41	0.52	-0.01	0.36	-0.28	0.5	0.07	0.34	0.67	0.0	0.34	0.01	0.22
End Period Cash Flow	-0.06	0.68	0.83	0.88	0.06	0.36	-0.06	-0.18	0.09	0.41		0.36	-0.31	0.17	-0.44	0.05	0.45	0.72	0.64	0.05	0.42	0.68	0.38
Stock Based Compensation	-0.78	-0.05	0.38	0.06	0.42	0.92	-0.33	0.56	0.31	0.52	0.36		-0.48	0.9	0.32	0.73	-0.51	-0.07	0.12	-0.47	0.78	-0.2	0.81
Change To Account Receivables	0.14	-0.36	-0.26	-0.02	0.18	-0.53	-0.25	-0.17	-0.09	-0.01	-0.31	-0.48		-0.43	0.14	-0.57	0.32	0.12	0.23	0.57	-0.27	-0.2	-0.65
Change To Netincome	-0.77	-0.14	0.3	-0.08	0.36	0.8	-0.25	0.58	0.17	0.36	0.17	0.9	-0.43		0.37	0.63	-0.57	-0.16	-0.06	-0.41	0.73	-0.27	0.74
Change Receivables	-0.44	-0.54	-0.44	-0.6	0.31	0.04	-0.22	0.3	-0.24	-0.28	-0.44	0.32	0.14	0.37		0.04	-0.7	-0.64	-0.52	-0.21	0.3	-0.67	0.35
Net Borrowings	-0.53	-0.13	0.02	-0.1	0.23	0.85	-0.25	0.7	0.68	0.5	0.05	0.73	-0.57	0.63	0.04		-0.51	-0.32	0.08	-0.69	0.24	-0.23	0.56
Cash And Cash Equivalents Changes	0.67	0.71	0.49	0.68	-0.52	-0.42	0.43	-0.62	-0.03	0.07	0.45	-0.51	0.32	-0.57	-0.7	-0.51		0.84	0.63	0.45	-0.33	0.83	-0.65
Cash Flows Other Operating	0.26	0.71	0.79	0.82	-0.25	-0.03	0.24	-0.39	0.02	0.34	0.72	-0.07	0.12	-0.16	-0.64	-0.32	0.84		0.72	0.38	0.17	0.8	-0.28
Change To Liabilities	-0.05	0.39	0.5	0.76	0.1	0.2	-0.19	0.0	0.57	0.67	0.64	0.12	0.23	-0.06	-0.52	0.08	0.63	0.72		0.11	-0.01	0.52	-0.17
Investments	0.26	0.0	0.09	0.12	0.05	-0.42	-0.06	-0.25	-0.32	0.0	0.05	-0.47	0.57	-0.41	-0.21	-0.69	0.45	0.38	0.11		0.06	0.05	-0.45
Exchange Rate Changes	-0.61	0.02	0.51	0.12	0.4	0.64	-0.24	0.34	-0.12	0.34	0.42	0.78	-0.27	0.73	0.3	0.24	-0.33	0.17	-0.01	0.06		-0.14	0.66
Change To Operating Activities	0.58	0.95	0.69	0.77	-0.63	-0.15	0.58	-0.57	-0.04	0.01	0.68	-0.2	-0.2	-0.27	-0.67	-0.23	0.83	0.8	0.52	0.05	-0.14		-0.24
Issuance Of Capital Stock	-0.69	-0.11	0.2	0.03	0.52	0.72	-0.42	0.45	0.06	0.22	0.38	0.81	-0.65	0.74	0.35	0.56	-0.65	-0.28	-0.17	-0.45	0.66	-0.24

Click cells to compare fundamentals

Universal Health Account Relationship Matchups

Universal Health cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Sale Purchase Of Stock	(770.5M)	(206.7M)	(1.2B)	(832.9M)	(547.4M)	(520.0M)
Change In Cash	(94.0M)	1.2B	(1.1B)	21.9M	13.6M	14.3M
Free Cash Flow	775.0M	1.6B	28.0M	262.0M	524.7M	551.0M
Change In Working Capital	58.8M	940.8M	53.4M	(244.3M)	17.1M	31.0M
Begin Period Cash Flow	199.7M	105.7M	1.3B	178.9M	200.8M	210.9M
Other Cashflows From Financing Activities	24.8M	789.5M	3.2B	648.3M	(4.4M)	(4.2M)
Depreciation	490.4M	510.5M	533.2M	581.9M	568.0M	596.4M
Other Non Cash Items	(97.8M)	(113.1M)	(790.3M)	(83.8M)	(122.5M)	(116.4M)
Dividends Paid	53.0M	17.3M	65.9M	58.4M	55.5M	34.3M
Capital Expenditures	663.5M	734.2M	855.7M	734.0M	743.1M	434.0M
Total Cash From Operating Activities	1.4B	2.4B	883.7M	996.0M	1.3B	640.5M
Net Income	827.5M	952.8M	987.6M	657.0M	717.5M	374.6M
Total Cash From Financing Activities	(845.0M)	(384.9M)	(1.1B)	(318.4M)	(493.9M)	(469.2M)
End Period Cash Flow	105.7M	1.3B	178.9M	200.8M	214.5M	225.2M
Stock Based Compensation	69.4M	65.8M	73.7M	85.4M	87.7M	92.1M
Other Cashflows From Investing Activities	(20.0M)	(46.8M)	1.5M	86.7M	78.0M	81.9M
Change To Account Receivables	(42.1M)	(145.9M)	(8.9M)	(258.3M)	(182.4M)	(173.3M)
Change To Netincome	167.1M	65.8M	99.7M	124.9M	143.6M	150.8M
Change Receivables	(46.7M)	(41.8M)	(155.9M)	(3.9M)	(3.5M)	(3.7M)
Net Borrowings	(17.9M)	(171.3M)	217.1M	616.0M	708.3M	743.8M
Total Cashflows From Investing Activities	(688.4M)	(802.6M)	(914.5M)	(647.3M)	(744.4M)	(781.6M)
Cash And Cash Equivalents Changes	35.3M	(95.0M)	1.2B	(1.1B)	(989.7M)	(940.3M)
Cash Flows Other Operating	365.7M	372.3M	1.2B	(292.2M)	(336.1M)	(319.3M)
Change To Liabilities	60.0M	157.5M	113.4M	268.4M	104.1M	0.0
Investments	(34.3M)	(24.4M)	1.4M	(647.3M)	(763.3M)	(725.1M)
Change To Operating Activities	28.3M	964.0M	(674.0M)	(98.5M)	(88.6M)	(84.2M)
Issuance Of Capital Stock	10.8M	12.3M	13.4M	14.1M	13.7M	13.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Universal Stock Analysis

When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Universal Historical Cash Flow

About Universal Cash Flow Analysis

Universal Health Cash Flow Chart

Begin Period Cash Flow

Dividends Paid

Capital Expenditures

Net Income

Total Cashflows From Investing Activities

Universal Health cash flow statement Correlations

Universal Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Universal Health cash flow statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Universal Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Change To Operating Activities	+ 0.95	Change In Cash
Stock Based Compensation	+ 0.92	Depreciation
Change To Netincome	+ 0.9	Stock Based Compensation
End Period Cash Flow	+ 0.88	Change In Working Capital
Net Borrowings	+ 0.85	Depreciation
Cash Flows Other Operating	+ 0.84	Cash And Cash Equivalents Changes

Other Non Cash Items	- 0.97	Begin Period Cash Flow
Begin Period Cash Flow	- 0.8	Sale Purchase Of Stock
Stock Based Compensation	- 0.78	Sale Purchase Of Stock
Change To Netincome	- 0.77	Sale Purchase Of Stock
Dividends Paid	- 0.72	Sale Purchase Of Stock
Cash And Cash Equivalents Changes	- 0.7	Change Receivables